Table 3 Breast cancer survival and Lysine decarboxylase.

From: Cadaverine, a metabolite of the microbiome, reduces breast cancer aggressiveness through trace amino acid receptors

Lysine decarboxylase (201744_s_at)

HR (Hazard Ratio)

P-value (Log Rank Test)

All Breast Cancers, N = 3951

1.07

0.23

ER(+), PR(+), N = 577

0.69

0.045

ER(+), PR(+), Lymph node(+), N = 344

0.52

3.4 × 10 − 3

ER(+), PR(+), Lymph node(−), N = 228

0.76

0.39

ER(−), PR(−), N = 298

0.94

0.74

ER(−), PR(−), Lymph node(+), N = 127

0.76

0.32

ER(−), PR(−), Lymph node(−), N = 167

0.89

0.69

ER(−), PR(−), HER2(−), N = 198

1.01

0.98

ER(+), Luminal A, N = 1933

1.15

0.1

ER(+), Luminal A, Grade 1, N = 267

0.45

0.014

ER(+), Luminal B, N = 1149

1.11

0.27

ER(+), Luminal B, Grade 1, N = 56

1.73

0.39

Grade 1, N = 345

0.6

0.055

Grade 2, N = 901

0.83

0.13

Grade 3, N = 903

1.06

0.59

Basal subtype, N = 618

1.18

0.19

Luminal A, N = 1933

1.15

0.1

Luminal B, N = 1149

1.11

0.27

ER(+), HER2(+), N = 156

0.96

0.9

ER(−), HER2(+), N = 96

1.57

0.16

Back to article page